Literature DB >> 27082931

Pregnancy-related pharmacokinetic changes.

Y Tasnif1, J Morado2, M F Hebert3.   

Abstract

The pharmacokinetics of many drugs are altered by pregnancy. Drug distribution and protein binding are changed by pregnancy. While some drug metabolizing enzymes have an apparent increase in activity, others have an apparent decrease in activity. Not only is drug metabolism affected by pregnancy, but renal filtration is also increased. In addition, pregnancy alters the apparent activities of multiple drug transporters resulting in changes in the net renal secretion of drugs.
© 2016 American Society for Clinical Pharmacology and Therapeutics.

Mesh:

Substances:

Year:  2016        PMID: 27082931     DOI: 10.1002/cpt.382

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  37 in total

Review 1.  Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.

Authors:  André Dallmann; Ibrahim Ince; Michaela Meyer; Stefan Willmann; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-11       Impact factor: 6.447

2.  Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women.

Authors:  Rodrigo Metzker Pereira Ribeiro; Fernanda de Lima Moreira; Elaine Christine Dantas Moisés; Ricardo Carvalho Cavalli; Silvana Maria Quintana; Vera Lucia Lanchote; Geraldo Duarte
Journal:  Br J Clin Pharmacol       Date:  2018-08-02       Impact factor: 4.335

3.  Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.

Authors:  Zufei Zhang; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2017-01-03       Impact factor: 3.922

4.  Physiologically-based pharmacokinetics of ziprasidone in pregnant women.

Authors:  Carla Biesdorf; Frederico S Martins; Sherwin K B Sy; Andrea Diniz
Journal:  Br J Clin Pharmacol       Date:  2019-03-11       Impact factor: 4.335

Review 5.  Clinical Pharmacokinetics and Pharmacodynamics of Anti-Tubercular Drugs in Pregnancy.

Authors:  Jennifer R Shiu; Alan Min; Tony K L Kiang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-01       Impact factor: 2.441

6.  Physiological Regulation of Drug Metabolism and Transport: Pregnancy, Microbiome, Inflammation, Infection, and Fasting.

Authors:  Edward T Morgan; Joseph L Dempsey; Sylvie M Mimche; Tracey J Lamb; Supriya Kulkarni; Julia Yue Cui; Hyunyoung Jeong; Angela L Slitt
Journal:  Drug Metab Dispos       Date:  2018-03-07       Impact factor: 3.922

7.  Roles of organic anion transporter 2 and equilibrative nucleoside transporter 1 in hepatic disposition and antiviral activity of entecavir during non-pregnancy and pregnancy.

Authors:  Zhiyuan Ma; Shuanghui Lu; Dongli Sun; Mengru Bai; Ting Jiang; Nengming Lin; Hui Zhou; Su Zeng; Huidi Jiang
Journal:  Br J Pharmacol       Date:  2019-07-10       Impact factor: 8.739

8.  A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.

Authors:  André Dallmann; Ibrahim Ince; Katrin Coboeken; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

9.  Population Pharmacokinetics of Sulindac and Genetic Polymorphisms of FMO3 and AOX1 in Women with Preterm Labor.

Authors:  Jin Won Sung; Hwi-Yeol Yun; Sunny Park; Young Ju Kim; Jeong Yee; Kyung Eun Lee; Byungjeong Song; Jee Eun Chung; Hye Sun Gwak
Journal:  Pharm Res       Date:  2020-01-28       Impact factor: 4.200

Review 10.  Methods to study mechanisms underlying altered hepatic drug elimination during pregnancy.

Authors:  Hyunyoung Jeong; Catherine S Stika
Journal:  Semin Perinatol       Date:  2020-01-25       Impact factor: 3.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.